# Comparison of Itraconazole With Itraconazole and Isotretinoin in the Treatment Duration, Safety a n d Cure Rate in Adult Patients of Tinea Corporis/ Cruris-A Randomised Controlled Trail

> **NCT07675239** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Pak Emirates Military Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Tinea Corporis

## Interventions

- **DRUG:** Itraconazole (200 mg)
- **DRUG:** ISOtretinoin 20 MG

## Key facts

- **NCT ID:** NCT07675239
- **Lead sponsor:** Pak Emirates Military Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675239, "Comparison of Itraconazole With Itraconazole and Isotretinoin in the Treatment Duration, Safety a n d Cure Rate in Adult Patients of Tinea Corporis/ Cruris-A Randomised Controlled Trail". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07675239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*